Stay updated on ELVN-002 in HER2 NSCLC Clinical Trial
Sign up to get notified when there's something new on the ELVN-002 in HER2 NSCLC Clinical Trial page.

Latest updates to the ELVN-002 in HER2 NSCLC Clinical Trial page
- Check5 days agoChange DetectedLocations updated: new sites across multiple countries added and some existing sites removed; page revision updated to v3.3.3.SummaryDifference1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing Revision: v3.2.0. This appears to be a minor internal version update with no impact on study content or user-facing features.SummaryDifference0.0%

- Check41 days agoChange DetectedThe study site list now includes Tainan, Taiwan, replacing Tainan City, Taiwan, and the government funding status notice was removed.SummaryDifference0.3%

- Check55 days agoChange DetectedThe screenshots show no substantial changes to core study details (conditions, interventions, endpoints, or locations) and any observed differences appear to be minor formatting or layout adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check84 days agoChange DetectedAdded a government-operating-status notice and a new version tag (v3.2.0); removed the old version tag (v3.1.0).SummaryDifference3%

- Check91 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0.SummaryDifference0.1%

Stay in the know with updates to ELVN-002 in HER2 NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ELVN-002 in HER2 NSCLC Clinical Trial page.